{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:45:21Z","timestamp":1792215921458,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK-106364"],"award-info":[{"award-number":["DK-106364"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcf.2026.09.016","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:56:06Z","timestamp":1792122966000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impaired insulin secretion in response to mixed meal ingestion is associated with hypersomatostatinemia in individuals with cystic fibrosis"],"prefix":"10.1016","author":[{"given":"Shana O.","family":"Warner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat H.","family":"Whitsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Sheanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair","family":"Hoeting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Indihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-8171","authenticated-orcid":false,"given":"Jason J.","family":"Winnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcf.2026.09.016_bib0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Saint-Criq","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"10290","key":"10.1016\/j.jcf.2026.09.016_bib0002","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.016_bib0003","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/db16-0394","article-title":"Reduced beta-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance","volume":"66","author":"Sheikh","year":"2017","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jcf.2026.09.016_bib0004","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/pedi.12700","article-title":"Beta-cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose >\/=155 mg\/dL","volume":"19","author":"Nyirjesy","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"10.1016\/j.jcf.2026.09.016_bib0005","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2337\/dc25-0044","article-title":"Trends in Cystic Fibrosis-related diabetes epidemiology between 2003 and 2018 from the U.S. Cystic Fibrosis Foundation patient registry","volume":"48","author":"Kohler","year":"2025","journal-title":"Diabetes care"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.016_bib0006","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(05)80032-0","article-title":"Pancreatic endocrine function in cystic fibrosis","volume":"118","author":"Moran","year":"1991","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.016_bib0007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc09-1215","article-title":"Diabetes as a determinant of mortality in cystic fibrosis","volume":"33","author":"Chamnan","year":"2010","journal-title":"Diabetes care"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.016_bib0008","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00125-020-05096-6","article-title":"Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis","volume":"63","author":"Aitken","year":"2020","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.jcf.2026.09.016_bib0009","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/clinem\/dgaa448","article-title":"Hypoglycemia and islet dysfunction following oral glucose tolerance testing in pancreatic-insufficient cystic fibrosis","volume":"105","author":"Kilberg","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.016_bib0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jcf.2019.07.006","article-title":"Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia","volume":"19","author":"Kilberg","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.016_bib0011","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jcf.2025.04.006","article-title":"The role of islet CFTR in the development of cystic fibrosis-related diabetes: A semi-systematic review","volume":"24","author":"Engstrom","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2026.09.016_bib0012","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98240","article-title":"Cystic fibrosis-related diabetes is caused by islet loss and inflammation","volume":"3","author":"Hart","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.jcf.2026.09.016_bib0013","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-3476(74)80756-0","article-title":"Endocrine function of the pancreas in cystic fibrosis: evidence for an impaired glucagon and insulin response following arginine infusion","volume":"84","author":"Stahl","year":"1974","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.09.016_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2026.03.021","article-title":"Research updates in cystic fibrosis related diabetes: understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research","author":"Putman","year":"2026","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.016_bib0015","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diabetes.53.2.426","article-title":"Insulin secretion in type 1 diabetes","volume":"53","author":"Steele","year":"2004","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2026.09.016_bib0016","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.2337\/diabetes.54.suppl_2.S32","article-title":"Natural history of beta-cell function in type 1 diabetes","volume":"54","author":"Sherry","year":"2005","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.jcf.2026.09.016_bib0017","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2337\/diab.14.10.619","article-title":"Pathologic anatomy of the pancreas in juvenile diabetes mellitus","volume":"14","author":"Gepts","year":"1965","journal-title":"Diabetes"},{"issue":"4135","key":"10.1016\/j.jcf.2026.09.016_bib0018","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1126\/science.184.4135.482","article-title":"Somatostatin: hypothalamic inhibitor of the endocrine pancreas","volume":"184","author":"Koerker","year":"1974","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.jcf.2026.09.016_bib0019","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/diab.23.11.876","article-title":"Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics","volume":"23","author":"Gerich","year":"1974","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jcf.2026.09.016_bib0020","first-page":"602","article-title":"Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study","volume":"110","author":"Abdul-Karim","year":"1986","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.016_bib0021","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc17-1387","article-title":"Islet interleukin-1beta immunoreactivity is an early feature of cystic fibrosis that may contribute to beta-cell failure","volume":"41","author":"Hull","year":"2018","journal-title":"Diabetes care"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.016_bib0022","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/adc.68.1.123","article-title":"Preservation of somatostatin secretion in cystic fibrosis patients with diabetes","volume":"68","author":"Meacham","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2026.09.016_bib0023","first-page":"E126","article-title":"A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs","volume":"277","author":"Galassetti","year":"1999","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.016_bib0024","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2337\/diacare.28.5.1001","article-title":"Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients","volume":"28","author":"Cozma","year":"2005","journal-title":"Diabetes care"},{"issue":"11","key":"10.1016\/j.jcf.2026.09.016_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/dia.2010.0083","article-title":"Repeatability of indices of insulin sensitivity and secretion from standard liquid meal tests in subjects with type 2 diabetes mellitus or normal or impaired fasting glucose","volume":"12","author":"Maki","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.jcf.2026.09.016_bib0026","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diacare.24.10.1706","article-title":"Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes","volume":"24","author":"Moran","year":"2001","journal-title":"Diabetes care"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.016_bib0027","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcf.2008.11.002","article-title":"Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study","volume":"8","author":"Hammana","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.016_bib0028","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1073\/pnas.73.1.248","article-title":"Does somatostatin inhibition of insulin secretion involve two mechanisms of action?","volume":"73","author":"Curry","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.jcf.2026.09.016_bib0029","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes care"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.016_bib0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1172\/JCI106297","article-title":"Studies of pancreatic alpha cell function in normal and diabetic subjects","volume":"49","author":"Unger","year":"1970","journal-title":"J clin investig"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.016_bib0031","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2337\/db18-1138","article-title":"Postprandial aminogenic insulin and glucagon secretion can stimulate glucose flux in humans","volume":"68","author":"Ang","year":"2019","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.jcf.2026.09.016_bib0032","first-page":"126","article-title":"Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man","volume":"22","author":"Johansson","year":"1981","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.016_bib0033","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1172\/JCI118379","article-title":"Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects","volume":"97","author":"Taylor","year":"1996","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.016_bib0034","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1172\/JCI117913","article-title":"A noninvasive method to measure splanchnic glucose uptake after oral glucose administration","volume":"95","author":"Ludvik","year":"1995","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.016_bib0035","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2337\/diabetes.48.5.1082","article-title":"Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis","volume":"48","author":"Hardin","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jcf.2026.09.016_bib0036","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2337\/diabetes.49.2.272","article-title":"Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity","volume":"49","author":"Basu","year":"2000","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.016_bib0037","doi-asserted-by":"crossref","first-page":"E1022","DOI":"10.1152\/ajpendo.2001.281.5.E1022","article-title":"Mechanisms of insulin resistance in cystic fibrosis","volume":"281","author":"Hardin","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.016_bib0038","first-page":"80","article-title":"Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis","volume":"79","author":"Austin","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jcf.2026.09.016_bib0039","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00125-024-06220-6","article-title":"Insulin sensitivity, disposition index and insulin clearance in cystic fibrosis: a cross-sectional study","volume":"67","author":"Nielsen","year":"2024","journal-title":"Diabetologia"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:30:22Z","timestamp":1792215022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326037690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S1569199326037690"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.016","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired insulin secretion in response to mixed meal ingestion is associated with hypersomatostatinemia in individuals with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}